Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
24.00    -1.00 (-4.00%)
Bid:
23.00
Ask:
25.00
Spread: 2.00 (8.696%)
Market Cap: £25.92m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Trading Update

10 Nov 2015 07:00

RNS Number : 1029F
Elektron Technology PLC
10 November 2015
 

Elektron Technology plc

(AIM: EKT, "Elektron" or the "Company" or the "Group")

 

Trading update and launch of new product

Elektron Technology plc , the global technology group, provides an update on third quarter trading.

Trading has continued the pattern of the first half of the financial year. Sales of products from brands in which the Group continues to invest strategically through new product development, namely Bulgin, Queensgate and Ophthalmic, are showing growth over the prior year. Bulgin is showing modest growth while Queensgate and Ophthalmic are in aggregate showing around 50% growth against prior year and now represent around 7.0% of total Group sales. The remaining brands that still account for a majority of the Group's sales are in low growth or declining markets, are experiencing weak demand and continue to track at levels below last year. This is expected to continue through the final quarter of the year. The Group is intensifying its cost cutting measures as a result.

The higher margin sales of products from invested brands, coupled with operational and overhead improvements implemented during the last 18 months, lead the Board to expect that the full year trading performance will be ahead of last year for existing businesses excluding Checkit which is effectively a start-up and is accounted for separately. 

The Board is pleased to confirm that the Checkit Work Management launch was on time and, despite the scale and complexity of the development, broadly in line with estimated development costs. The Group remains on track to launch a significant further enhancement to Checkit's product offering early next year.

Elektron remains committed to its twin strategies of delivering efficiency and productivity improvements in its established businesses and investing in new product development to generate future growth.

Group net debt was approximately £1.5m at 31 October (31 July 2015: £2.1m; 31 January 2015: £2.7m; 31 October 2014: £2.7m). It is anticipated that given the traditional profile of sales, debt levels are unlikely to fall further in the last quarter and may show a slight rise due to working capital movements. The Board is particularly pleased to note that the Group continues both to reduce debt at the same time as investing in new products.

John Wilson, Chief Executive of Elektron, said:

"Although we are somewhat cautious about the trading outlook given current market conditions, performance has so far held up well. We were greatly encouraged by the market reaction to the new Checkit Work Management system at its launch a few weeks ago. The task now is to convert the strong interest into orders. We expect to announce further new product launches shortly."

For further information:

 

Elektron Technology www.elektron-technology.com

+44 (0)1223 371 000

John Wilson - Chief Executive Officer

Andy Weatherstone - Chief Financial Officer

 

finnCap (Nominated Adviser and Broker)

+44 (0)20 7220 0500

Ed Frisby/Scott Mathieson (Corporate Finance)

Malar Velaigam (Corporate Broking)

 

Notes to Editors

 

Elektron conceives, designs and markets innovative engineered products and services for businesses that connect, monitor and control

 

We have a multi skilled team of engineers, software and product line specialists based in Cambridge focused on the opportunities created by global trends in the following areas:

 

-- New waves of "aware" business applications: Checkit

-- Demand for ubiquitous power and data: Bulgin

-- Growth in high precision manufacture: Queensgate

 

In addition, Elektron owns a portfolio of well-established products and brands that provide cash flow as well as customer access and feedback

Forward looking statements

Statements contained in this trading statement are based on the knowledge and information available to the Company's directors at the date it was prepared and therefore the facts stated and views expressed may change after that date. By their nature, the statements concerning the risks and uncertainties facing the Company in this Statement involve uncertainty since future events and circumstances can cause results and developments to differ materially from those anticipated. To the extent that this Statement contains any statement dealing with any time after the date of its preparation such statement is merely predictive and speculative as it relates to events and circumstances which are yet to occur. The Company undertakes no obligation to update these forward looking statements.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFSAFWUFISEFF
Date   Source Headline
10th Apr 20187:00 amRNSCheckit passes £1 million annual recurring revenue
29th Mar 20187:00 amRNSBulgin announces agreement with Arrow Electronics
6th Mar 20187:00 amRNSFSA successfully completes trials with Checkit
27th Feb 20187:00 amRNSHolding(s) in Company
16th Feb 20187:00 amRNSDisposal of Queensgate Nano
8th Feb 20187:00 amRNSTrading Statement
26th Jan 20183:37 pmRNSHolding(s) in Company
25th Jan 20185:58 pmRNSHolding(s) in Company
25th Jan 20187:00 amRNSAcquisition of IP in EET business
19th Jan 20183:45 pmRNSHolding(s) in Company
2nd Jan 20187:00 amRNSChange of Nominated Adviser and Broker
12th Dec 20177:00 amRNSGrant of Options
6th Dec 20174:02 pmRNSHolding(s) in Company
2nd Nov 20177:00 amRNSTrading Statement
23rd Oct 20174:16 pmRNSDirector/PDMR Shareholding
20th Oct 20177:00 amRNSDisposal of Sheen Instruments
16th Oct 201712:25 pmRNSHolding(s) in Company
27th Sep 20174:20 pmRNSHolding(s) in Company
21st Sep 20177:00 amRNSHalf-year Report
19th Sep 20177:00 amRNSContract Win
10th Aug 20177:00 amRNSTrading Update and Notification of Interim Results
31st Jul 20177:00 amRNSDisposal
13th Jul 201710:01 amRNSHolding(s) in Company
6th Jul 20173:00 pmRNSResult of AGM
6th Jul 20177:00 amRNSAGM Statement
16th Jun 201710:40 amRNSHolding(s) in Company
13th Jun 20177:57 amRNSHolding(s) in Company
6th Jun 201711:26 amRNSAnnual Report and Notice of AGM
18th May 20177:00 amRNSFinal Results
2nd May 20177:00 amRNSNotice of Results & AGM
27th Mar 20177:00 amRNSDisposal
8th Feb 20177:00 amRNSTrading Update
19th Jan 20177:00 amRNSDirector/PDMR Shareholding
14th Dec 20164:54 pmRNSHolding(s) in Company
13th Dec 20167:00 amRNSDirector/PDMR Shareholding
8th Dec 20169:00 amRNSReview of Operations
2nd Dec 20167:00 amRNSDisposal
30th Sep 20162:43 pmRNSDisposal of Carnation Designs
22nd Sep 20167:00 amRNSHalf-year Report
30th Aug 20169:52 amRNSHolding(s) in Company
1st Aug 20167:00 amRNSDirector/PDMR Shareholding
28th Jul 20163:56 pmRNSResult of AGM
28th Jul 20167:00 amRNSTrading Update
4th Jul 201610:40 amRNSLapsing of Options
30th Jun 20167:00 amRNSAnnual Report and Notice of AGM
9th Jun 20167:00 amRNSFinal Results
23rd May 20167:00 amRNSDisposal of Agar Scientific
18th May 20169:56 amRNSHolding(s) in Company
13th May 201610:06 amRNSHolding(s) in Company
20th Apr 20162:54 pmRNSDerivative Claim - Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.